KLK3 and prostate carcinoma: In a longitudinal observational study enrolling 4,511 men with newly diagnosed prostate cancer between 1986 and 2004, Kasper et al. demonstrated the increased risk of prostate cancer in diabetic men after PSA era compared with that in pre-PSA era, although the odds ratio still remained low after PSA era (0.86) [17].